Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu, Heehyoung Lee, Andreas Herrmann, et al.
Nature reviews. Cancer (2014) Vol. 14, Iss. 11, pp. 736-746
Closed Access | Times Cited: 1904

Showing 1-25 of 1904 citing articles:

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1390
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell, Lisa M. Coussens
Cancer Cell (2015) Vol. 27, Iss. 4, pp. 462-472
Open Access | Times Cited: 1289
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin, Soma Kobayashi, Andrew M. Leader, et al.
Cell (2017) Vol. 169, Iss. 4, pp. 750-765.e17
Open Access | Times Cited: 1055
Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1033
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones, Brendan J. Jenkins
Nature reviews. Immunology (2018) Vol. 18, Iss. 12, pp. 773-789
Closed Access | Times Cited: 867
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 865
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang, Ding Ma, Chen Suo, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 428-440.e5
Open Access | Times Cited: 745
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen, Natasha K. Brockwell, Belinda S. Parker
Cancers (2019) Vol. 11, Iss. 12, pp. 2002-2002
Open Access | Times Cited: 527
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Azucena Salas, Cristian Hernández-Rocha, Marjolijn Duijvestein, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 6, pp. 323-337
Closed Access | Times Cited: 464
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 2, pp. 82-96
Closed Access | Times Cited: 444
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 438
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Youzhi Li, Harry A. Rogoff, Sarah Keates, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 6, pp. 1839-1844
Open Access | Times Cited: 424
Iron and cancer: recent insights
David H. Manz, Nicole Blanchette, Bibbin T. Paul, et al.
Annals of the New York Academy of Sciences (2016) Vol. 1368, Iss. 1, pp. 149-161
Open Access | Times Cited: 420
Aptamer-based targeted therapy
Guizhi Zhu, Xiaohong Chen
Advanced Drug Delivery Reviews (2018) Vol. 134, pp. 65-78
Open Access | Times Cited: 411
Targeted protein degradation: mechanisms, strategies and application
Lin Zhao, Jia Zhao, Kunhong Zhong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 396
Adipocyte and lipid metabolism in cancer drug resistance
Yihai Cao
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3006-3017
Open Access | Times Cited: 386
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin, Jelena Grahovac, Anamaria Brozović, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100715-100715
Open Access | Times Cited: 381
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 351
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Mukaddes Izci, Christy Maksoudian, Bella B. Manshian, et al.
Chemical Reviews (2021) Vol. 121, Iss. 3, pp. 1746-1803
Open Access | Times Cited: 350
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik, Hamidreza Montazeri Aliabadi
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 336
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar, Pingyan Cheng, Thomas Condamine, et al.
Immunity (2016) Vol. 44, Iss. 2, pp. 303-315
Open Access | Times Cited: 335
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Marcel Klingenberg, Akiko Matsuda, Sven Diederichs, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 3, pp. 603-619
Open Access | Times Cited: 326
Transcriptional regulation of myeloid-derived suppressor cells
Thomas Condamine, Jérôme Mastio, Dmitry I. Gabrilovich
Journal of Leukocyte Biology (2015) Vol. 98, Iss. 6, pp. 913-922
Open Access | Times Cited: 324
Role of STAT3 signaling pathway in breast cancer
Jiahui Ma, Li Qin, Xia Li
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 319
Page 1 - Next Page

Scroll to top